Tue 05/17/2022 13:12 PM
GenesisCare financial analysis by Reorg's EMEA Core Credit team.
GenesisCare shareholders are in talks with external investors over a capital raise, sources told Reorg.
The Australia-based oncology services group had previously told lenders that its current shareholders - KKR, China Resources Holding and management - had committed to providing the 100 million Australian dollars ($69.3 million) equity injection the company had
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2022 Reorg Research, Inc. All rights reserved.